Zion Pharma Limited

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Gilead Takes On XinThera’s Preclinical

Since China performed a sudden and drastic U-turn and dismantled most of its restrictive policies related to COVID-19 late last year, biopharma companies are embracing a unique opportunity to catch up

With the success of AstraZeneca PLC and Daiichi Sankyo Co., Ltd. ’s Enhertu (fam-trastuzumab daruxtecan-nxki), a number of drug makers are hoping to get in on the HER2 game as well, in some cases l